Anne-Claire Fougerousse
Overview
Explore the profile of Anne-Claire Fougerousse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
43
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Perrot J, Maccari F, Guillem P, Fougerousse A, Nassif A, Beneton N, et al.
Clin Cosmet Investig Dermatol
. 2022 Jun;
15:1091-1103.
PMID: 35734147
Purpose: Hidradenitis suppurativa (HS) is an inflammatory skin disease characterized by recurrent or chronic painful and suppurating lesions in the apocrine gland-bearing regions. The lack of knowledge about HS and...
12.
van Huizen A, Menting S, Gyulai R, Iversen L, van der Kraaij G, Middelkamp-Hup M, et al.
JAMA Dermatol
. 2022 Mar;
158(5):561-572.
PMID: 35353175
Importance: A clear dosing regimen for methotrexate in psoriasis is lacking, and this might lead to a suboptimal treatment. Because methotrexate is affordable and globally available, a uniform dosing regimen...
13.
McBride S, Fargnoli M, Fougerousse A, Garcia Bustinduy M, Catton L, Senturk L, et al.
Int J Womens Dermatol
. 2022 Jan;
7(5Part B):697-707.
PMID: 35028368
Background: Plaque psoriasis (PSO) is a long-term inflammatory condition that can cause concomitant joint symptoms (psoriatic arthritis [PsA]) in up to 30% of patients. The impact of psoriatic disease on...
14.
Phan C, Beauchet A, Reguiai Z, Severino-Freire M, Mazereeuw-Hautier J, Bursztejn A, et al.
Pediatr Dermatol
. 2021 Dec;
39(1):35-41.
PMID: 34888920
Background: There is currently little information on switching biologics in pediatric psoriasis. Objective: To evaluate the real-world clinical practice and safety of switching biologics in the "Biological Treatments for Pediatric...
15.
Ezanno A, Fougerousse A, Guillem P
Int Wound J
. 2021 Sep;
19(4):802-810.
PMID: 34590422
No abstract available.
16.
Cohen-Sors R, Fougerousse A, Reguiai Z, Maccari F, Mahe E, Delaunay J, et al.
Clin Cosmet Investig Dermatol
. 2021 Jul;
14:845-854.
PMID: 34267533
Background: Few studies addressing the safety and efficacy of biological therapy (BT) or apremilast (APR) in patients with psoriasis with a history of hematologic malignancy (HM) exist. Aim: To describe...
17.
Fougerousse A, Mery-Bossard L, Parier J, Taieb C, Bertolotti A, Maccari F
Clin Cosmet Investig Dermatol
. 2021 May;
14:389-393.
PMID: 33935509
Purpose: To evaluate the modalities of methotrexate prescription for moderate to severe psoriasis by dermatologists in France. Patients And Methods: We performed a national online practice survey between October and...
18.
Fougerousse A, Jacobzone C, Mery-Bossard L, Reguiai Z, Droitcourt C, Taieb C, et al.
Clin Cosmet Investig Dermatol
. 2021 Mar;
14:179-183.
PMID: 33658822
Purpose: Recent studies have illustrated that systemic medications are underused for treating adult atopic dermatitis (AD) and that dermatologists have concerns regarding the safety profile of cyclosporine in AD. Patients...
19.
Fougerousse A
Dermatol Ther (Heidelb)
. 2021 Feb;
11(2):331-338.
PMID: 33523410
Dr Anne-Claire Fougerousse is Head of Dermatology at the Bégin Hospital in Saint-Mandé, France, and scientific coordinator of a French network of dermatologists and allergists (ResoEczema). The focus of her...
20.
Phan C, Beneton N, Delaunay J, Reguiai Z, Boulard C, Fougerousse A, et al.
Acta Derm Venereol
. 2020 Oct;
100(18):adv00316.
PMID: 33111960
Anti-interleukin-17 agents have recently been developed for the treatment of psoriasis. This study evaluated the tolerance and effectiveness of anti-interleukin-17 agents for psoriasis in elderly patients in daily practice. A...